World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
51317
World Ranking
6422
National Ranking
3420

Ted Feldman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ted Feldman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 540 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ted Feldman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ted Feldman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ted Feldman is affiliated with Edwards Lifesciences in the United States and specializes in medicine, with a primary focus on cardiology and cardiovascular medicine. Their research encompasses several subfields including epidemiology, surgery, radiology, nuclear medicine and imaging, and pathology and forensic medicine.

The scientist's work chiefly revolves around cardiac valve diseases and treatments, infective endocarditis diagnosis and management, and cardiac structural anomalies and repair. Other research topics include cardiovascular function and risk factors, cardiac pacing and defibrillation studies, cardiac imaging and diagnostics, and coronary interventions and diagnostics.

Frequent publication venues for this researcher include:

  • JACC: Cardiovascular Interventions
  • Journal of the American College of Cardiology
  • The American Journal of Cardiology
  • Circulation Cardiovascular Interventions
  • EuroIntervention

Notable recent papers include:

  • Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation, 2021, Journal of the American College of Cardiology
  • Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States, 2020, Circulation Cardiovascular Interventions
  • Tricuspid valve repair with the Cardioband system: two-year outcomes of the multicentre, prospective TRI-REPAIR study, 2021, EuroIntervention
  • Impact of tricuspid regurgitation on survival in patients with heart failure: a large electronic health record patient-level database analysis, 2020, European Journal of Heart Failure
  • 1-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study, 2020, JACC: Cardiovascular Interventions

Collaborations have often involved several frequently coauthoring experts in the field, including Martin B. Leon, Susheel Kodali, Mackram F. Eleid, Robert Kipperman, and Michael J. Mack, with the number of joint publications ranging from 10 to 15.

Best Publications

  • Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease

    Patrick W. Serruys;Marie-Claude Morice;A. Pieter Kappetein;Antonio Colombo

  • Percutaneous Repair or Surgery for Mitral Regurgitation

    Ted Feldman;Elyse Foster;Donald G. Glower;Saibal Kar

  • ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention).

    Sidney C. Smith;Ted E. Feldman;John W. Hirshfeld;Alice K. Jacobs

  • Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease : 5-year follow-up of the randomised, clinical SYNTAX trial

    Friedrich W. Mohr;Marie Claude Morice;A. Pieter Kappetein;Ted E. Feldman

  • 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association task force on practice guidelines

    Spencer B. King;Sidney C. Smith;John W. Hirshfeld;Alice K. Jacobs

  • ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

    Sidney C. Smith;Ted E. Feldman;John W. Hirshfeld;Alice K. Jacobs

  • Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.

    Ted Feldman;Saibal Kar;Michael Rinaldi;Peter Fail

  • Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II

    Vasim Farooq;David Van Klaveren;Ewout W. Steyerberg;Emanuele Meliga

  • Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial.

    Ted Feldman;Hal S. Wasserman;Howard C. Herrmann;William Gray

  • Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial

    Marie Claude Morice;Patrick W. Serruys;A. Pieter Kappetein;Ted E. Feldman

  • Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation 5-Year Results of EVEREST II

    Ted Feldman;Saibal Kar;Sammy Elmariah;Steven C. Smart

  • Assessment of the SYNTAX score in the Syntax study

    Patrick W. Serruys;Yoshinobu Onuma;Scot Garg;Giovanna Sarno

  • Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial

    Arie Pieter Kappetein;Ted E. Feldman;Michael J. MacK;Marie Claude Morice

  • The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.

    Juan F. Viles-Gonzalez;Saibal Kar;Pamela Douglas;Srinivas Dukkipati

  • Acute and 12-Month Results With Catheter-Based Mitral Valve Leaflet Repair: The EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study

    Patrick L. Whitlow;Ted Feldman;Wes R. Pedersen;D. Scott Lim

  • Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial

    Marie Claude Morice;Patrick W. Serruys;A. Pieter Kappetein;Ted E. Feldman

  • Sex-associated differences in left ventricular function in aortic stenosis of the elderly.

    J D Carroll;E P Carroll;T Feldman;D M Ward

  • Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.

    Daniel J F M Thuijs;A Pieter Kappetein;Patrick W Serruys;Friedrich-Wilhelm Mohr

  • The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: Results of the TIMI III registry ECG ancillary study

    C P Cannon;C H McCabe;P H Stone;W J Rogers

  • 4-Year Results of a Randomized Controlled Trial of Percutaneous Repair Versus Surgery for Mitral Regurgitation

    Laura Mauri;Laura Mauri;Elyse Foster;Donald D. Glower;Patricia Apruzzese

Frequent Co-Authors

Elyse Foster
Elyse Foster University of California, San Francisco
David R. Holmes
David R. Holmes Mayo Clinic
Keith D. Dawkins
Keith D. Dawkins Boston Scientific (United States)
Patrick W. Serruys
Patrick W. Serruys University of Galway
Antonio Colombo
Antonio Colombo Humanitas Clinical and Research Center IRCCS
Donald D. Glower
Donald D. Glower Duke University
Howard C. Herrmann
Howard C. Herrmann University of Pennsylvania
Friedrich W. Mohr
Friedrich W. Mohr Leipzig University
Michael J. Mack
Michael J. Mack Scott & White Memorial Hospital
Laura Mauri
Laura Mauri University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring pathways into medicine often leads students to consider nursing as a flexible and rewarding career. Many prospective and current nurses are turning to online programs for greater accessibility and affordability. For those looking to advance their careers, an online nursing doctorate offers the highest level of nursing education and opens doors to leadership, research, and academic positions.

If you already hold an RN license, enrolling in the cheapest rn to bsn program can boost your credentials while keeping costs manageable. For those without a nursing background, direct entry nurse practitioner programs for non-nurses online provide an accelerated path to advanced practice roles—even if your undergraduate degree is in another field.

Some students prioritize accessibility and seek options that increase their chances of admission. Direct admit nursing programs offer straightforward entry into nursing studies without complicated prerequisites.

Whether you’re starting your journey or advancing your qualifications, these online pathways offer flexible solutions to meet your career goals in healthcare.

Best Scientists Citing Ted Feldman

Trending Scientists

Recently Published Articles